Efficacy of prostaglandin E1 in relieving obstruction in coarctation of a persistent fifth aortic arch without opening the ductus arteriosus

Sheilia J Carroll; Anne Ferris; Jonathan Chen; Leonardo Liberman

doi:10.1007/s00246-006-1380-6

Efficacy of prostaglandin E1 in relieving obstruction in coarctation of a persistent fifth aortic arch without opening the ductus arteriosus

Pediatr Cardiol. 2006 Nov-Dec;27(6):766-8. doi: 10.1007/s00246-006-1380-6. Epub 2006 Nov 16.

Authors

Sheilia J Carroll¹, Anne Ferris, Jonathan Chen, Leonardo Liberman

Affiliation

¹ Pediatric Cardiology, New York-Presbyterian Hospital, 3959 Broadway, 2 North, New York, NY 10032, USA.

PMID: 17111291
DOI: 10.1007/s00246-006-1380-6

Abstract

A persistent fifth aortic arch (PFAA) with coarctation and type A interruption of the fourth arch was recognized in a 9-day-old infant. The widening of the area of coarctation in the fifth arch with prostaglandin E1 infusion without opening the ductus arteriosus is presented to document that ectopic ductal tissue constriction contributes to the development of coarctation in PFAA.

Publication types

Case Reports

MeSH terms

Alprostadil / administration & dosage
Alprostadil / therapeutic use*
Aorta / diagnostic imaging
Aorta, Thoracic / abnormalities*
Aortic Coarctation / complications
Aortic Coarctation / drug therapy*
Coronary Angiography
Female
Humans
Infant, Newborn
Ultrasonography

Substances

Alprostadil